SI-BONE, Inc. (SIBN)

Market Cap	572.04M
Revenue (ttm)	157.04M
Net Income (ttm)	-37.40M
Shares Out	41.94M
EPS (ttm)	-0.91
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70,802
Open	13.54
Previous Close	13.72
Day's Range	13.20 - 13.74
52-Week Range	11.70 - 21.64
Beta	1.18
Analysts	Strong Buy
Price Target	23.00 (+68.62%)
Earnings Date	Feb 24, 2025

About SIBN

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; i...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 17, 2018
• Employees: 344
• Stock Exchange: NASDAQ
• Ticker Symbol: SIBN
• Website: https://si-bone.com

Financial Performance

In 2023, SI-BONE's revenue was $138.89 million, an increase of 30.52% compared to the previous year's $106.41 million. Losses were -$43.34 million, -29.25% less than in 2022.

Analyst Forecast

According to 6 analysts, the average rating for SIBN stock is "Strong Buy." The 12-month stock price forecast is $23.0, which is an increase of 68.62% from the latest price.

Price Target

$23.0

(68.62% upside)

Analyst Consensus: Strong Buy